Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1976-05-10
1978-01-17
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
2602395, 424238, A61K 4300, C07J 1700
Patent
active
040693058
ABSTRACT:
Derivatives of steroids containing an imidazole group specifically bind to the desired antibody without nonspecifically binding to other substances (e.g., proteins in a patient's plasma or serum and the surfaces of reaction vessels).
REFERENCES:
foster et al, Clinical Chemistry, vol. 20, No. 3, Mar., 1974, pp.365-368.
Farmer et al, Clinical Chemistry, vol. 20, No. 4, Apr., 1974, pp. 411-414.
McKenzie et al, J. of Clinical Endocrinology and Metabolism, vol. 38, No. 4, Apr., 1974, pp.622-627.
Newsome et al, Radioimmunoassay and Related Procedures in Medicine, vol. II, International Atomic Energy Agency, Vienna, 1974, pp. 79-85.
Knight William S.
Polito Alan J.
Beckman Instruments Inc.
Frieman Robert S.
Nucker Christine M.
Padgett Benjamin R.
Steinmeyer Robert J.
LandOfFree
I.sup.125 Imidazole steroid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with I.sup.125 Imidazole steroid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and I.sup.125 Imidazole steroid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2282457